Erratum
Effects of Alum Adjuvant or a Booster Dose on Immunogenicityduring Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines
L. C. Paoletti, M. A. Rench, D. L. Kasper, D. Molrine, D. Ambrosino, C. J. Baker
L. C. Paoletti
Channing Laboratory, Brigham and Women’s Hospital, and Children’s Hospital Medical Center, Harvard MedicalSchool, Boston, Massachusetts 02115, and Baylor College of Medicine, Houston, Texas 77030
M. A. Rench
Channing Laboratory, Brigham and Women’s Hospital, and Children’s Hospital Medical Center, Harvard MedicalSchool, Boston, Massachusetts 02115, and Baylor College of Medicine, Houston, Texas 77030
D. L. Kasper
Channing Laboratory, Brigham and Women’s Hospital, and Children’s Hospital Medical Center, Harvard MedicalSchool, Boston, Massachusetts 02115, and Baylor College of Medicine, Houston, Texas 77030
D. Molrine
Channing Laboratory, Brigham and Women’s Hospital, and Children’s Hospital Medical Center, Harvard MedicalSchool, Boston, Massachusetts 02115, and Baylor College of Medicine, Houston, Texas 77030
D. Ambrosino
Channing Laboratory, Brigham and Women’s Hospital, and Children’s Hospital Medical Center, Harvard MedicalSchool, Boston, Massachusetts 02115, and Baylor College of Medicine, Houston, Texas 77030
C. J. Baker
Channing Laboratory, Brigham and Women’s Hospital, and Children’s Hospital Medical Center, Harvard MedicalSchool, Boston, Massachusetts 02115, and Baylor College of Medicine, Houston, Texas 77030
DOI: 10.1128/IAI.70.1.426-426.2002

- American Society for Microbiology
Effects of Alum Adjuvant or a Booster Dose on Immunogenicityduring Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines
L. C. Paoletti, M. A. Rench, D. L. Kasper, D. Molrine, D. Ambrosino, C. J. Baker
Infection and Immunity Jan 2002, 70 (1) 426; DOI: 10.1128/IAI.70.1.426-426.2002